Crossref journal-article
Oxford University Press (OUP)
Human Molecular Genetics (286)
Bibliography

Tantisira, K. G., Small, K. M., Litonjua, A. A., Weiss, S. T., & Liggett, S. B. (2005). Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between β-agonist and corticosteroid pathways. Human Molecular Genetics, 14(12), 1671–1677.

Authors 5
  1. Kelan G. Tantisira (first)
  2. Kersten M. Small (additional)
  3. Augusto A. Litonjua (additional)
  4. Scott T. Weiss (additional)
  5. Stephen B. Liggett (additional)
References 28 Referenced 102
  1. Chung, F., Fabbri, L.M. (eds) (2003) Asthma, ERS Journals Ltd., Sheffield, UK, Vol. 8. pp. 1–458.
  2. Masoli, M., Fabian, D., Holt, S. and Beasley, R. (2004) The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy, 59, 469–478. (10.1111/j.1398-9995.2004.00526.x)
  3. Raby, B.A. and Weiss, S.T. (2001) Beta2-adrenergic receptor genetics. Curr. Opin. Mol. Ther., 3, 554–566.
  4. Drazen, J.M., Silverman, E.K. and Lee, T.H. (2000) Heterogeneity of therapeutic responses in asthma. Br. Med. Bull., 56, 1054–1070. (10.1258/0007142001903535)
  5. Green, S.A. and Liggett, S.B. (1996) G-Protein-Coupled Receptor Signaling in the Lung. In Liggett, S. and Meyers, D. (eds), The Genetics of Asthma. Marcel Dekker, Inc., New York, pp. 67–90.
  6. Billington, C.K., Hall, I.P., Mundell, S.J., Parent, J.L., Panettieri, R.A., Benovic, J.L. and Penn, R.B. (1999) Inflammatory and contractile agents sensitize specific adenylyl cyclase isoforms in human airway smooth muscle. Am. J. Respir. Cell Mol. Biol., 21, 597–606. (10.1165/ajrcmb.21.5.3759)
  7. Paul, R.J., de Lanerolle, P., Liggett, S.B. and Meyers, D. (1996) Regulation of Smooth Muscle Contractility. In Liggett, S. and Meyers, D. (eds), Genetics of Asthma. Marcel Dekker, Inc., New York, pp. 91–117.
  8. Lima, J.J., Thomason, D.B., Mohamed, M.H.N., Eberle, L.V., Self, T.H. and Johnson, J.A. (1999) Pharmacodynamics and drug action: impact of genetic polymorphisms of the b2-adrenergic receptor on albuterol bronchodilator pharmacodynamics. Clin. Pharmacol. Ther., 65, 519–525. (10.1016/S0009-9236(99)70071-8)
  9. Drysdale, C.M., McGraw, D.W., Stack, C.B., Stephens, J.C., Judson, R.S., Nandabalan, K., Arnold, K., Ruano, G. and Liggett, S.B. (2000) Complex promoter and coding region b2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc. Natl Acad. Sci. USA, 97, 10483–10488. (10.1073/pnas.97.19.10483)
  10. Silverman, E.K., Kwiatkowski, D.J., Sylvia, J.S., Lazarus, R., Drazen, J.M., Lange, C., Laird, N.M. and Weiss, S.T. (2003) Family-based association analysis of beta2-adrenergic receptor polymorphisms in the childhood asthma management program. J. Allergy Clin. Immunol., 112, 870–876. (10.1016/S0091-6749(03)02023-2)
  11. Israel, E., Chinchilli, V.M., Ford, J.G., Boushey, H.A., Cherniack, R.M., Craig, T.J., Deykin, A., Fagan, J.K., Fahy, J.V., Fish, J. et al. (2004) Genotype stratified prospective cross-over trial of regularly scheduled albuterol treatment in asthma. Lancet, 364, 1505–1512. (10.1016/S0140-6736(04)17273-5)
  12. Post, S.R., Hilal-Dandan, R., Urasawa, K., Brunton, L.L. and Insel, P.A. (1995) Quantification of signalling components and amplification in the beta-adrenergic-receptor-adenylate cyclase pathway in isolated adult rat ventricular myocytes. Biochem. J., 11, 75–80. (10.1042/bj3110075)
  13. Lynch, R.A., Wagoner, L.E., Li, S., Sparks, L., Molkentin, J. and Dorn, G.W.2. (2002) Novel and nondetected human signaling protein polymorphisms. Physiol. Genomics, 10, 159–168. (10.1152/physiolgenomics.00030.2002)
  14. Weinstein, L.S., Liu, J., Sakamoto, A., Xie, T. and Chen, M. (2004) Minireview: GNAS: normal and abnormal functions. Endocrinology, 145, 5459–5464. (10.1210/en.2004-0865)
  15. Barnes, P.J. (1995) Beta-adrenergic receptors and their regulation. Am. J. Respir. Crit. Care Med., 152, 838–860. (10.1164/ajrccm.152.3.7663795)
  16. Michel, M.C., Knapp, J. and Ratjen, H. (1994) Sensitization by dexamethasone of lymphocyte cyclic AMP formation: evidence for increased function of the adenylyl cyclase catalyst. Br. J. Pharmacol., 113, 240–246. (10.1111/j.1476-5381.1994.tb16200.x)
  17. Aksoy, M.O., Mardini, I.A., Yang, Y., Bin, W., Zhou, S. and Kelsen, S.G. (2002) Glucocorticoid effects on the beta-adrenergic receptor-adenylyl cyclase system of human airway epithelium. J. Allergy Clin. Immunol., 109, 491–497. (10.1067/mai.2002.122154)
  18. Small, K.M., Brown, K.M., Theiss, C.T., Seman, C.A., Weiss, S.T. and Liggett, S.B. (2003) An Ile to Met polymorphism in the catalytic domain of adenylyl cyclase type 9 confers reduced b2-adrenergic receptor stimulation. Pharmacogenetics, 13, 535–541. (10.1097/00008571-200309000-00002)
  19. Israel, E., Chinchilli, V.M., Ford, J.G., Boushey, H.A., Cherniack, R., Craig, T.J., Deykin, A., Fagan, J.K., Fahy, J.V., Fish, J. et al. (2004) Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet, 364, 1505–1512. (10.1016/S0140-6736(04)17273-5)
  20. Schaid, D.J., Rowland, C.M., Tines, D.E., Jacobson, R.M. and Poland, G.A. (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet., 70, 425–434. (10.1086/338688)
  21. Bockaert, J., Fagni, L., Dumuis, A. and Marin, P. (2004) GPCR interacting proteins (GIP). Pharmacol. Ther., 103, 203–221. (10.1016/j.pharmthera.2004.06.004)
  22. Druey, K.M. (2001) Bridging with GAPs: receptor communication through RGS proteins. Sci. STKE., 2001, RE14. (10.1126/stke.2001.104.re14)
  23. Mialet-Perez, J., Green, S.A., Miller, W.E. and Liggett, S.B. (2004) A primate-dominant third glycosylation site of the b2-adrenergic receptor routes receptors to degradation during agonist regulation. J. Biol. Chem., 279, 38603–38607. (10.1074/jbc.M403708200)
  24. Perez, J.M., Rathz, D.A., Petrashevskaya, N.N., Hahn, H.S., Wagoner, L.E., Schwartz, A., Dorn, G.W.I. and Liggett, S.B. (2003) b1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nat. Med., 9, 1300–1305. (10.1038/nm930)
  25. The Childhoood Asthma Management Program Research Group (2000) Long-term effects of budesonide or nedocromil in children with asthma. N. Engl. J. Med., 343, 1054–1063. (10.1056/NEJM200010123431501)
  26. Sun, X., Ding, H., Hung, K. and Guo, B. (2000) A new MALDI-TOF based mini-sequencing assay for genotyping of SNPS. Nucleic Acids Res., 28, E68. (10.1093/nar/28.12.e68)
  27. Pritchard, J.K. and Rosenberg, N.A. (1999) Use of unlinked genetic markers to detect population stratification in association studies. Am. J. Hum. Genet., 65, 220–228. (10.1086/302449)
  28. Pritchard, J.K., Stephens, M., Rosenberg, N.A. and Donnelly, P. (2000) Association mapping in structured populations. Am. J. Hum. Genet., 67, 170–181. (10.1086/302959)
Dates
Type When
Created 20 years, 3 months ago (May 6, 2005, 4:49 p.m.)
Deposited 6 years, 6 months ago (Feb. 18, 2019, 12:57 a.m.)
Indexed 2 weeks, 3 days ago (Aug. 20, 2025, 9:10 a.m.)
Issued 20 years, 4 months ago (May 6, 2005)
Published 20 years, 4 months ago (May 6, 2005)
Published Online 20 years, 4 months ago (May 6, 2005)
Published Print 20 years, 2 months ago (June 15, 2005)
Funders 0

None

@article{Tantisira_2005, title={Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between β-agonist and corticosteroid pathways}, volume={14}, ISSN={0964-6906}, url={http://dx.doi.org/10.1093/hmg/ddi175}, DOI={10.1093/hmg/ddi175}, number={12}, journal={Human Molecular Genetics}, publisher={Oxford University Press (OUP)}, author={Tantisira, Kelan G. and Small, Kersten M. and Litonjua, Augusto A. and Weiss, Scott T. and Liggett, Stephen B.}, year={2005}, month=may, pages={1671–1677} }